Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian Adults, Adolescent, Children and Infants

NCT04741828 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.

NCT NCT04741828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04741828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian Adults, Adolescent, Children and Infants
Lead sponsor
PT Bio Farma
Phase
Phase 2/3
Overall status
Completed
Start date
May 3, 2021
Completion date
December 30, 2024
Enrollment
188 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

vaccine